25-01345 Spartan Capital Securities, LLC v. TC BioPharm Holdings PLC
FINRA Dispute Resolution Services · Securities (FINRA) · United States · October 22, 2025
Why it matters
Spartan Capital Securities, LLC v. TC BioPharm Holdings PLC, decided in FINRA arbitration. In this case Spartan Capital Securities, LLC, a member firm, brought a claim against an individual (often a former employee or registered representative). For a student, it shows how FINRA arbitration works: the binding, largely private forum where the great majority of US securities disputes are resolved instead of the courts, with awards enforceable in court and open to challenge only on narrow grounds.
Summary
Spartan Capital Securities, LLC v. TC BioPharm Holdings PLC: a FINRA arbitration award (case 25-01345), 05/13/2026. The panel's decision is set out in the award.
The detail
Parties: Spartan Capital Securities, LLC v. TC BioPharm Holdings PLC
Case number: FINRA Case No. 25-01345
Outcome: Award for the claimant of $300,000.00.
Quantum: $300,000.00
Applicable law: FINRA Code of Arbitration Procedure; United States securities law; the parties' brokerage agreement.
Issues in play: An investor's or an industry member's claim, decided in FINRA's arbitration forum rather than the courts.
Read the full decision at FINRA Arbitration Awards Online ↗
Locus Standi links to the source decision and publishes its own plain-language summary. It does not reproduce the text of the award.